title: Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment.
abstract: BACKGROUND
  A prospective, randomized clinical trial to assess the effect of reducing the volume of irradiated normal tissue on acute reactions in pelvic radiotherapy accured 266 evaluable patients between 1988 and 1993.
  
  
  OBJECTIVE
  This is the definitive analysis to assess the differences between the conformal and conventional arms of the trial.
  
  
  METHODS
  In both arms, patients were treated with 6 MV X-rays using a 3-field technique (in all but 5 cases) consisting of an anterior and two wedged lateral or posterior oblique fields; in the conventional arm, rectangular fields were employed, whereas in the conformal arm, the fields were shaped with customized blocks drawn according to the beam's-eye-view of the target volume. The most common dosage was 64 Gy in 2-Gy fractions 5 times a week, although a subgroup (of ca. bladder patients) were treated with 30-36 Gy in once-a-week 6 Gy fractions. Each patients completed a comprehensive acute toxicity scoring questionnaire concentrating on bowel and bladder problems, tiredness and nausea, before the start of treatment, weekly during and for 3 weeks after the end of treatment and then monthly for a further 2 months. compliance was excellent.
  
  
  RESULTS
  There were no differences between the patients in the two arms with respect to age, gender, tumour type (52% prostate, 41% bladder, 5% rectum, 2% other) fractionation/dosage, anterior field size, weight, or baseline symptoms. Substantial differences in normal-tissue volumes (rectum, bladder, etc.) were achieved: median high-dose volume (HDV) of 689 cm3 for the conformal technique versus 792 cm3 for the conventional. A clear pattern of an increase in symptoms during RT, followed by a decrease after RT, was observed for the patient group as a whole. However, a very extensive analysis has not revealed any (statistically) significant differences between the two arms in level of symptoms, nor in medication prescribed. The disparity between our findings and those of other, non-randomized studies is discussed.
  
  
  CONCLUSIONS
  The data on late effects must be collected and analyzed before any definite conclusions can be drawn on the benefits of conformal therapy in the pelvis.
authors.affiliation: Department of Radiotherapy, Royal Marsden NHS Trust, Sutton, UK.
authors.forename: D M
authors.initials: DM
authors.lastname: Tait
authors.forename: A E
authors.initials: AE
authors.lastname: Nahum
authors.forename: L C
authors.initials: LC
authors.lastname: Meyer
authors.forename: M
authors.initials: M
authors.lastname: Law
authors.forename: D P
authors.initials: DP
authors.lastname: Dearnaley
authors.forename: A
authors.initials: A
authors.lastname: Horwich
authors.forename: W P
authors.initials: WP
authors.lastname: Mayles
authors.forename: J R
authors.initials: JR
authors.lastname: Yarnold
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003672:Defecation / Q000528:radiation effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D010386:Pelvic Neoplasms / Q000532:radiotherapy*; D011446:Prospective Studies; D011829:Radiation Dosage; D011878:Radiotherapy / Q000009:adverse effects; D011881:Radiotherapy, Computer-Assisted; D011795:Surveys and Questionnaires; D014554:Urination / Q000528:radiation effects; D014839:Vomiting / Q000209:etiology